Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2019 | 2 |
2024 | 2 |
Search Results
4 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Long-term effectiveness and safety of edoxaban in patients with atrial fibrillation: 4-year data from the ETNA-AF-Europe study.
Int J Cardiol. 2024 Aug 1;408:132118. doi: 10.1016/j.ijcard.2024.132118. Epub 2024 Apr 30.
Int J Cardiol. 2024.
PMID: 38697397
Free article.
Characteristics of patients initiated on edoxaban in Europe: baseline data from edoxaban treatment in routine clinical practice for patients with atrial fibrillation (AF) in Europe (ETNA-AF-Europe).
De Caterina R, Kelly P, Monteiro P, Deharo JC, de Asmundis C, López-de-Sá E, Weiss TW, Waltenberger J, Steffel J, de Groot JR, Levy P, Bakhai A, Zierhut W, Laeis P, Kerschnitzki M, Reimitz PE, Kirchhof P; ETNA-AF-Europe investigators.
De Caterina R, et al.
BMC Cardiovasc Disord. 2019 Jul 12;19(1):165. doi: 10.1186/s12872-019-1144-x.
BMC Cardiovasc Disord. 2019.
PMID: 31299906
Free PMC article.
Item in Clipboard
Design and rationale of the Edoxaban Treatment in routiNe clinical prActice for patients with Atrial Fibrillation in Europe (ETNA-AF-Europe) study.
De Caterina R, Kelly P, Monteiro P, Deharo JC, de Asmundis C, López-de-Sá E, Weiss TW, Waltenberger J, Steffel J, de Groot JR, Levy P, Bakhai A, Zierhut W, Laeis P, Reimitz PE, Kirchhof P; ETNA-AF-Europe investigators.
De Caterina R, et al.
J Cardiovasc Med (Hagerstown). 2019 Feb;20(2):97-104. doi: 10.2459/JCM.0000000000000737.
J Cardiovasc Med (Hagerstown). 2019.
PMID: 30540648
Free article.
Item in Clipboard
Incidence and Predictors of Worsening Renal Function in Edoxaban-Treated Atrial Fibrillation Patients Within ETNA-AF-Europe Registry.
Gwechenberger M, Barón-Esquivias G, de Vries TAC, Siller-Matula JM, Manu MC, Souza JAG, Wienerroither S, Pecen L, de Groot JR, De Caterina R, Kirchhof P; ETNA-AF-Europe Investigators.
Gwechenberger M, et al.
JACC Adv. 2024 Mar 11;3(4):100880. doi: 10.1016/j.jacadv.2024.100880. eCollection 2024 Apr.
JACC Adv. 2024.
PMID: 38939675
Free PMC article.
Item in Clipboard
Cite
Cite